A novel approach to oral apoA-I mimetic therapy[S]
Transgenic tomato plants were constructed with an empty vector (EV) or a vector expressing an apoA-I mimetic peptide, 6F. EV or 6F tomatoes were harvested, lyophilized, ground into powder, added to Western diet (WD) at 2.2% by weight, and fed to LDL receptor-null (LDLR−/−) mice at 45 mg/kg/day 6F. A...
Main Authors: | Arnab Chattopadhyay, Mohamad Navab, Greg Hough, Feng Gao, David Meriwether, Victor Grijalva, James R. Springstead, Mayakonda N. Palgnachari, Ryan Namiri-Kalantari, Feng Su, Brian J. Van Lenten, Alan C. Wagner, G.M. Anantharamaiah, Robin Farias-Eisner, Srinivasa T. Reddy, Alan M. Fogelman |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2013-04-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520422047 |
Similar Items
-
Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally[S]
by: Mohamad Navab, et al.
Published: (2011-06-01) -
Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis
by: Mohamad Navab, et al.
Published: (2015-04-01) -
A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids
by: Mohamad Navab, et al.
Published: (2009-08-01) -
Lipoprotein inflammatory properties and serum amyloid A levels but not cholesterol levels predict lesion area in cholesterol-fed rabbits
by: Brian J. Van Lenten, et al.
Published: (2007-11-01) -
Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid[S]
by: Mohamad Navab, et al.
Published: (2013-12-01)